Jinyu Bio-technology Co., Ltd. (SHA:600201)
China flag China · Delayed Price · Currency is CNY
11.90
-0.10 (-0.83%)
Nov 17, 2026, 3:00 PM CST

Jinyu Bio-technology Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
1,4691,2651,1401,7121,4051,334
Trading Asset Securities
232.66120.1136.8337.2746.94183.85
Cash & Short-Term Investments
1,7021,3851,1761,7491,4521,518
Cash Growth
22.56%17.74%-32.76%20.46%-4.32%-29.58%
Accounts Receivable
832.38601.17648.83869.84816.65742.88
Other Receivables
33.3863.9845.1444.3757.2941.49
Receivables
865.76665.15693.97914.21873.94904.5
Inventory
235.96269.13294.64322.25333.46317.65
Prepaid Expenses
-0.013.493.45-1.07
Other Current Assets
62.1124.422.9326.5120.9119.4
Total Current Assets
2,8662,3442,1913,0162,6812,761
Property, Plant & Equipment
1,7751,8871,8301,8921,7991,819
Long-Term Investments
173.121,3051,8291,0251,0191,058
Goodwill
139.188.28.211.4129.4994.5
Other Intangible Assets
507.12572.27586.76352.12347.32388.45
Long-Term Deferred Tax Assets
126.38126.54107.3696.9983.4386.15
Long-Term Deferred Charges
153.73118.4369.84378.12322.53260.16
Other Long-Term Assets
875.77250.28142.28100.48107.87136.86
Total Assets
6,6166,6126,7656,8736,3896,604

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
286.72256.02295.84324.41354.41347.05
Accrued Expenses
36.4473.358.8576.96101.36102.82
Short-Term Debt
--15.01-10.01-
Current Portion of Leases
0.671.431.481.530.530.62
Current Income Taxes Payable
59.729.984.076.9213.397.82
Current Unearned Revenue
81.03101.45105.1498.3884.6582.55
Other Current Liabilities
181.31278.36244.67332.2594.39148.29
Total Current Liabilities
645.89720.53725.06840.45658.75689.15
Long-Term Debt
270-----
Long-Term Leases
0.030.151.252.730.310.16
Long-Term Unearned Revenue
302.03331.75345.32364.84370.49343.9
Long-Term Deferred Tax Liabilities
7.518.299.369.6310.1510.48
Other Long-Term Liabilities
3-268.29---
Total Liabilities
1,2281,0611,3491,2181,0401,044

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
1,1001,1121,1201,1201,1201,126
Additional Paid-In Capital
720751.85764.9891.52834.3893.34
Retained Earnings
3,9853,8003,6933,6733,4563,366
Treasury Stock
-485.99-242.3-209.67-338.48-338.48-113.34
Comprehensive Income & Other
-53.16-53.16-53.920.46-0.41-0.23
Total Common Equity
5,2665,3685,3145,3675,0725,272
Minority Interest
121.55182.81101.04288.06277.45287.98
Shareholders' Equity
5,3885,5515,4155,6555,3505,560
Total Liabilities & Equity
6,6166,6126,7656,8736,3896,604

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
270.71.5817.744.2710.850.78
Net Cash (Debt)
1,4311,3831,1591,7451,4421,517
Net Cash Growth
4.30%19.41%-33.61%21.07%-4.99%-29.61%
Net Cash Per Share
1.291.241.061.601.301.35
Filing Date Shares Outstanding
1,1451,2231,1171,1171,0871,103
Total Common Shares Outstanding
1,1451,2231,1171,1171,0871,103
Working Capital
2,2201,6231,4662,1752,0222,071
Book Value Per Share
4.604.394.764.804.664.78
Tangible Book Value
4,6204,7884,7195,0034,6954,789
Tangible Book Value Per Share
4.033.914.224.484.324.34
Buildings
-1,3011,2741,1531,1521,128
Machinery
-1,4611,4511,35450.021,272
Construction In Progress
-365.22201.48359.22151.72128.74